Stock Spotlights Archives

FridayMay 08, 2026 3:18 pm

TinyGemsBreaks – Frontieras North America Inc. Advancing FASForm(TM) for Domestic, Feedstock-Driven Energy Production

Frontieras is positioned amid increased demand for domesticenergy production. “At the core of its strategy is Frontieras’s FASForm(TM) process, which the company describes as a solid carbon fractionation technology that separates coal into its constituent components,” reads a recent article. “What Frontieras is building in Mason County is not a coal mine… It is not a power plant. It is not a refinery in the traditional sense,” the company’s CEO Matt McKean is quoted as saying. “It is the first commercial-scale deployment of FASForm Solid Carbon Fractionation, a patented, zero-waste process that takes coal and disassembles it at the molecular level…

FridayApr 24, 2026 3:22 pm

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Integrating AI and Imaging to Redefine Train Safety Systems

Rail Vision (NASDAQ: RVSN) is poised for opportunity as the global train collision avoidance market is undergoing a dramatic transformation, driven by the convergence of advanced camera systems and artificial intelligence. The company is “developing proprietary AI-integrated sensing platforms designed to detect hazards in real time and ultimately enable fully autonomous train operations,” reads a recent article. “Israel-based Rail Vision has built its technology around the idea that the most dangerous moments for a train are the ones no one planned for. The company’s offerings have been described as AI-powered perception systems that allow rail operators to predict and prevent collisions, operating…

FridayApr 24, 2026 2:59 pm

TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Unlocking New Potential in Precision Cancer Treatment

LIXTE Biotechnology Holdings (NASDAQ: LIXT) is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. “The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects,” reads a recent article. “By focusing on improving the therapeutic index of existing cancer modalities, the company is tackling a recurrent challenge in the field of oncology: maximizing treatment impact while cutting down risks to healthy tissue.” To view the full article, visit https://ibn.fm/EE6ya About LIXTE Biotechnology Holdings Inc. LIXTE…

FridayApr 17, 2026 2:14 pm

TinyGemsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Deploys AI, Thermal Imaging to Redefine Rail Safety

Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail Vision develops vision-based detection systems designed to improve railway safety and operational performance, offering real-time obstacle detection and situational awareness that align closely with evolving safety priorities across the industry,” reads a recent article. “Rail Vision’s AI-powered electro-optical sensor systems are designed to address key railway safety challenges by integrating wide-field and narrow-field electro-optic cameras to provide a complete ‘safety envelope’ around the train. The company’s solutions include the use of thermal cameras that…

FridayApr 17, 2026 1:27 pm

TinyGemsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness. By inhibiting PP2A, the compound stimulates cell-cycle progression and interferes with DNA repair in cancer cells, potentially making tumors more responsive to chemotherapy and immunotherapy. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with significant unmet medical need, including ovarian clear…

FridayFeb 20, 2026 2:36 pm

TinyGemsBreaks – GridAI Technologies Corp. (NASDAQ: GRDX) Poised at Convergence of Electrification, EV Growth and AI Demand

GridAI Technologies (NASDAQ: GRDX), a company operating at the intersection of artificial intelligence and energy infrastructure, is positioned for opportunity as the power grid has become a central battleground for the next phase of AI growth. An article discussing this reads, “The company is developing grid and power-management software aimed at hyperscale AI data center campuses. Its core proposition is that the limiting factor for AI infrastructure is no longer only compute capacity, but the ability to control and optimize energy at scale… This challenge is structural. Modern grids were designed for predictable demand patterns and centralized generation. AI data…

WednesdayOct 01, 2025 2:45 pm

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Sets Standard in High-Performance E-Boat Space

Vision Marine Technologies Inc. (NASDAQ: VMAR) was featured in a recent article that discusses its positioning and commitment to revolutionizing the boating experience. The company “has long demonstrated its leadership in marine electrification, with its E-Motion(TM) 180E-powered vessel holding the world record for the fastest electric boat. Set at the annual Lake of the Ozarks Shootout in Missouri, the record shows that VMAR’s craft reached an astonishing speed of 116 mph, surpassing its own previous record of 109 mph, set in 2022. This enduring achievement continues to underscore Vision Marine’s commitment to innovation and excellence in the electric marine industry.” “We’re in a…

FridayJun 13, 2025 3:40 pm

TinyGemsBreaks – SolarBank Corp.’s (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Forest Hill Rd Project Adds to Growing Development Pipeline

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) was featured in a recent article that discussed its momentum with the development of its Forest Hill Rd solar project in upstate New York. “The 4.584 megawatt DC installation will operate as a community solar facility, contributing renewable energy to the local grid and offering cost savings to approximately 540 homes,” reads the article. “The project adds to SolarBank’s growing development pipeline, which now exceeds one gigawatt and already includes several solar projects in upstate New York. It also represents continued expansion in the U.S. market at…

TuesdayJun 10, 2025 1:06 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Taps Biotech Veteran to Lead Next Phase of Growth

Calidi Biotherapeutics (NYSE American: CLDI) recently announced the appointment of Eric Poma, PhD, as its new chief executive officer and member of the board of directors. The company was featured in an article that reads, “As Calidi Biotherapeutics continues to pioneer targeted antitumor virotherapies, the appointment of Dr. Poma as CEO represents a strategic move to harness experienced leadership for the company’s next phase of growth. His extensive background in oncology, successful track record in fundraising and strategic partnerships, and comprehensive understanding of the biotech landscape position him to effectively steer Calidi’s innovative therapies through clinical development and toward commercialization.” To…

ThursdayMay 22, 2025 3:11 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) RTNova Shows Promise in Targeted Tumor Therapy

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted tumors. The innovative platform not only targets cancer cells effectively but also minimizes harm to surrounding healthy tissues, potentially improving treatment outcomes and reducing side effects. As global cancer rates continue to rise, Calidi’s RTNova platform and tumor-specific virotherapy hold the promise of offering new hope to cancer patients, addressing the limitations of existing treatments, and potentially improving survival rates across multiple cancer types. The company’s ongoing research and deep commitment to scientific excellence position…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: Stock Spotlights